靜脈輸液幫浦市場規模、佔有率和成長分析（按產品、適應症、最終用途和地區）- 產業預測 2025-2032

靜脈輸液幫浦市場規模預計在 2023 年達到 162.4 億美元，並從 2024 年的 175.4 億美元成長到 2032 年的 324.6 億美元，預測期內（2025-2032 年）的複合年成長率為 8.0%。

由於慢性病的增加、人口老化和醫療技術的進步，全球靜脈輸液幫浦市場預計將大幅成長。輸液幫浦是許多醫療保健環境中必不可少的設備，因為它們可以精確地將液體和藥物直接輸送到血液中。對需要持續輸液治療的居家醫療服務的需求不斷成長以及臨床環境中準確給藥的需求進一步推動了市場成長。此外，對減少用藥錯誤和提高病人安全性的關注也在推動這個市場的發展。展望未來，採用使用者友善的連網型設備、資料驅動技術和以患者為中心的設計將成為滿足醫療保健提供者和患者不斷變化的需求的關鍵。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

靜脈輸液幫浦市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 容積式輸液泵
• 胰島素輸注泵
• 注射輸液幫浦
• 腸內輸注泵
• 攜帶式輸液泵

靜脈輸液幫浦市場規模（按適應症和複合年成長率） (2025-2032)

• 市場概況
• 糖尿病
• 化療
• 血液學
• 其他

靜脈輸液幫浦市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 療養院
• 居家照護

靜脈輸液幫浦市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• B. Braun Melsungen AG（Germany）
• Baxter International Inc.（USA）
• Becton, Dickinson and Company（USA）
• ICU Medical, Inc.（USA）
• Medtronic PLC（Ireland）
• Fresenius Kabi AG（Germany）
• Smiths Group plc（UK）
• Terumo Corporation（Japan）
• Mindray Medical International Limited（China）
• Moog Inc.（USA）
• Zyno Medical（USA）
• Advanced Instrumentations（USA）
• Micrel Medical Devices（Greece）
• Plenum Tech（USA）
• Sino Medical-Device Technology Co., Ltd.（China）
• Insulet Corporation（USA）
• Tandem Diabetes Care, Inc.（USA）
• vTitan Corporation Pvt. Ltd.（India）
• Nipro Corporation（Japan）

結論和建議

Intravenous Infusion Pump Market size was valued at USD 16.24 billion in 2023 and is poised to grow from USD 17.54 billion in 2024 to USD 32.46 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The global intravenous (IV) infusion pump market is poised for substantial growth, driven by an increase in chronic diseases, an aging population, and advancements in medical technology. These essential devices enable the precise delivery of fluids and medications directly into the bloodstream, making them vital in various healthcare settings. The rising demand for home healthcare services requiring continuous infusion therapies and the imperative for accurate drug administration in clinical environments further enhance market growth. Additionally, the focus on minimizing medication errors and improving patient safety is propelling this market forward. Moving ahead, the introduction of user-friendly, connected devices, alongside data-driven technologies and patient-centric designs, will be crucial in meeting the evolving needs of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Intravenous Infusion Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Intravenous Infusion Pump Market Segments Analysis

Global Intravenous Infusion Pump Market is segmented by Product, Disease Indication, End-use and region. Based on Product, the market is segmented into Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps and Ambulatory Infusion Pumps. Based on Disease Indication, the market is segmented into Diabetes, Chemotherapy, Hematology and Others. Based on End-use, the market is segmented into Hospitals, Nursing Homes and Home Care. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Intravenous Infusion Pump Market

The rising incidence of chronic diseases like cancer, diabetes, and cardiovascular ailments, along with the aging global population, significantly propels the demand for intravenous (IV) infusion pumps. These vital devices play a crucial role in delivering medications, fluids, and nutrients with precision to patients undergoing prolonged treatments, thereby enhancing disease management and promoting better health outcomes. As healthcare systems increasingly prioritize accurate and efficient treatment methods, the necessity for advanced IV infusion pumps continues to grow, reflecting the broader trends in patient care and chronic disease management on a worldwide scale.

Restraints in the Intravenous Infusion Pump Market

The intravenous infusion pump market faces significant restraints due to the high costs associated with the purchase and maintenance of advanced models. The initial financial investment, combined with ongoing expenses for calibration, regular maintenance, and staff training, can create substantial strains on healthcare budgets. This economic burden poses a significant challenge for healthcare facilities, especially those operating in resource-constrained environments or regions with limited financial resources. As a result, the affordability and accessibility of these critical devices may be compromised, ultimately impacting the delivery of quality healthcare in various settings.

Market Trends of the Intravenous Infusion Pump Market

The intravenous infusion pump market is witnessing a strong shift towards smart and connected devices, reflecting broader digital healthcare trends. These innovative infusion pumps are equipped with advanced features such as dose calculation assistance, integration with electronic health records (EHR), and real-time monitoring, significantly enhancing patient safety and operational efficiency. The demand for such technology-driven solutions is rising as healthcare providers seek to minimize medication errors and improve workflow processes. Additionally, the trend of remote monitoring capabilities allows for timely adjustments in patient care, underscoring the increasing importance of connectivity and automation in modern healthcare environments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Intravenous Infusion Pump Market Size by Product & CAGR (2025-2032)

• Market Overview
• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Enteral Infusion Pumps
• Ambulatory Infusion Pumps

Global Intravenous Infusion Pump Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Diabetes
• Chemotherapy
• Hematology
• Others

Global Intravenous Infusion Pump Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Nursing Homes
• Home Care

Global Intravenous Infusion Pump Market Size & CAGR (2025-2032)

• North America (Product, Disease Indication, End-use)
  • US
  • Canada
• Europe (Product, Disease Indication, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Disease Indication, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Disease Indication, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Disease Indication, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moog Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zyno Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Instrumentations (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micrel Medical Devices (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Plenum Tech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Medical-Device Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• vTitan Corporation Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations